These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19436037)

  • 1. Small beginnings: do they matter? The importance of lymphovascular invasion in early breast cancer.
    Chivukula M; Brufsky A; Davidson NE
    J Natl Cancer Inst; 2009 May; 101(10):698-9. PubMed ID: 19436037
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation between c-erbB2 expression, lymphovascular invasion and other biological and clinical prognostic factors and preoperative tumor markers in patients with early-stage and locally advanced breast cancer.
    Aksu G; Duman C; Gurbuz Y; Ercin C; Canturk Z; Utkan Z; Dulger M
    J BUON; 2011; 16(1):52-7. PubMed ID: 21674850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BP1, a putative signature marker for inflammatory breast cancer and tumor aggressiveness.
    Man YG; Schwartz A; Levine PH; Teal C; Berg PE
    Cancer Biomark; 2009; 5(1):9-17. PubMed ID: 19242057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
    Cho KS; Seo HK; Joung JY; Park WS; Ro JY; Han KS; Chung J; Lee KH
    J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Occult multicentric breast cancer].
    Vtorushin SV; Zab'ialova MV; Glushchenko SA; Perel'muter VM; Slonimskaia EM
    Vopr Onkol; 2009; 55(1):38-41. PubMed ID: 19435197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic markers and long-term prognosis in breast cancer.
    Burtness BA
    Cancer J Sci Am; 1997; 3(4):211-2. PubMed ID: 9263626
    [No Abstract]   [Full Text] [Related]  

  • 7. Issues relating to lymphovascular invasion in breast carcinoma.
    Hoda SA; Hoda RS; Merlin S; Shamonki J; Rivera M
    Adv Anat Pathol; 2006 Nov; 13(6):308-15. PubMed ID: 17075296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer.
    Debled M; de Mascarel I; Brouste V; Mauriac L; MacGrogan G
    J Natl Cancer Inst; 2010 Feb; 102(4):275-6; author reply 276-7. PubMed ID: 20042719
    [No Abstract]   [Full Text] [Related]  

  • 9. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.
    Millar EK; Graham PH; O'Toole SA; McNeil CM; Browne L; Morey AL; Eggleton S; Beretov J; Theocharous C; Capp A; Nasser E; Kearsley JH; Delaney G; Papadatos G; Fox C; Sutherland RL
    J Clin Oncol; 2009 Oct; 27(28):4701-8. PubMed ID: 19720911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presenting features of breast cancer differ by molecular subtype.
    Wiechmann L; Sampson M; Stempel M; Jacks LM; Patil SM; King T; Morrow M
    Ann Surg Oncol; 2009 Oct; 16(10):2705-10. PubMed ID: 19593632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular invasion in breast cancer; an overview of recent prognostic developments and molecular pathophysiological mechanisms.
    Mohammed RA; Ellis IO; Lee AH; Martin SG
    Histopathology; 2009 Jul; 55(1):1-9. PubMed ID: 19016903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular markers of breast axillary lymph node metastasis.
    Cavalli LR
    Expert Rev Mol Diagn; 2009 Jul; 9(5):441-54. PubMed ID: 19580429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of spread of the neoplastic process on prognosis in breast cancer].
    Ostrovtsev LD
    Khirurgiia (Mosk); 1983 Nov; (11):40-3. PubMed ID: 6664007
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of forkhead box protein 3 expression in invasive breast cancer.
    Wolf AM; Rumpold H; Wolf D; Gastl G; Reimer D; Jenewein N; Marth C; Zeimet AG
    J Clin Oncol; 2007 Oct; 25(28):4499-500; author reply 4500-1. PubMed ID: 17906214
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of early breast cancer and precancerous condition].
    Zwaveling A
    Ned Tijdschr Geneeskd; 1976 Nov; 120(4-):2107-10. PubMed ID: 1012353
    [No Abstract]   [Full Text] [Related]  

  • 16. Distant metastasis after radical treatment of breast cancer: risk factors and their prognostic relevance in 378 consecutive patients.
    Daskalova I; Popovska S; Betova T; Velkova A; Ivanova N; Baitchev G; Delijski T
    J BUON; 2009; 14(2):229-33. PubMed ID: 19650171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A rare case of small-cell diffuse invasive breast lobular carcinoma].
    Novitskaia TA; Turkevich EA; Ellinidi VN
    Arkh Patol; 2009; 71(4):54-5. PubMed ID: 19824433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic pitfalls in mammary pathology. Case 8. Breast metastases of a malignant melanoma].
    Dauplat MM; Penault-Llorca F
    Ann Pathol; 2009 Jun; 29(3):228-32. PubMed ID: 19619831
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer.
    Shah FD; Shukla SN; Shah PM; Shukla HK; Patel PS
    Indian J Cancer; 2009; 46(3):194-202. PubMed ID: 19574670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to disease recurrence in basal-type breast cancers: effects of tumor size and lymph node status.
    Dent R; Hanna WM; Trudeau M; Rawlinson E; Sun P; Narod SA
    Cancer; 2009 Nov; 115(21):4917-23. PubMed ID: 19691094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.